Related Experiment Video
Updated: Jun 29, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Pulmonary tumors in childhood
1Department of Thoracic Surgery, Ankara University Faculty of Medicine, Ankara, Türkiye.
Childhood pulmonary tumors are rare but often malignant. Diagnosis is challenging due to nonspecific symptoms, necessitating tailored surgical and adjuvant therapies based on tumor type and stage.
Area of Science:
- Pediatric Oncology
- Thoracic Surgery
- Pathology
Background:
- Pulmonary tumors in children are uncommon but frequently malignant.
- A wide range of histopathologic types exist, presenting diagnostic challenges.
- Nonspecific clinical and radiological signs often lead to delayed or inaccurate diagnoses.
Purpose of the Study:
- To review the diverse histopathologic spectrum of pediatric pulmonary tumors.
- To highlight the diagnostic difficulties associated with these rare neoplasms.
- To outline current treatment strategies, emphasizing the role of surgery and adjuvant therapy.
Main Methods:
- Review of literature on pediatric pulmonary tumors.
- Analysis of histopathologic classifications.
- Discussion of diagnostic criteria and therapeutic approaches.
Main Results:
- The histopathologic spectrum includes inflammatory myofibroblastic tumor, hamartoma, paraganglioma, carcinoid tumor, mucoepidermoid carcinoma, pleuropulmonary blastoma, adenocarcinoma, squamous cell carcinoma, and sarcomas.
- Diagnostic delays are common due to nonspecific clinical and imaging findings.
- Surgical resection is the primary treatment, with adjuvant therapy guided by tumor characteristics.
Conclusions:
- Pediatric pulmonary tumors represent a heterogeneous group with a predominantly malignant nature.
- Accurate histopathologic diagnosis is crucial for effective management.
- Treatment requires a multidisciplinary approach, integrating surgical expertise with adjuvant therapies tailored to individual tumor profiles.
More Related Videos
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Other Pulmonary Disorders
Pulmonary Cycle: Exhalation
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: